To access this element change to forms mode OFF

Current Grant Opportunity View - GO3825

MRFF – 2020 Antiviral Development for COVID-19 Grant Opportunity

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address:

Web Address:

GO ID:
GO3825
Agency:
National Health and Medical Research Council (NHMRC)
Close Date & Time:
8-Apr-2020 5:00 pm (ACT Local Time)
Show close time for other time zones
Internal Reference ID:
round/23
Primary Category:
231013 - Medical Research
Publish Date:
25-Mar-2020
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive

Description:

Applications to this Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Antiviral Development for COVID-19 grant opportunity must propose research to rapidly identify antiviral candidates targeting SARS-CoV-2 (new and repurposed) and accelerate promising effective treatments that can be made available to treat Australians infected with SARS-CoV-2.

A competitive two stage funding process will be used:

Stage 1: Funding of up to $3 million will be provided to support testing of up to 10 antiviral candidates for stability, safety and effectiveness against SARS-CoV-2 to demonstrate proof of concept. Stage 1 projects are to be completed within 9 months of commencement.

Stage 2: Funding of up to $5 million will support acceleration of promising antiviral candidates from Stage 1 into clinical practice, enabling clinical trials in humans, progression through regulatory pathways and/or transition to commercialisation. Stage 2 projects are to be completed within 24 months of commencement.

Applicants should note that the research funded by this grant opportunity is not intended to be used for vaccine development or respiratory medicine research for COVID-19. These issues are the subject of separate MRFF grant opportunities.

This opportunity is supported by the Medical Research Future Fund (MRFF).

Eligibility:

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available on GrantConnect and on the NHMRC website: https://nhmrc.gov.au/funding/manage-your-funding/nhmrcs-administering-institutions

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Antiviral Development for COVID-19 Grant Opportunity Guidelines

Total Amount Available (AUD):
$8,000,000.00
Instructions for Application Submission:

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Administering Institution that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online Granting System (Sapphire).

https://healthandmedicalresearch.gov.au/

Other Instructions:

Questions should be submitted no later than 1:00pm ACT Local Time on Monday 6 April 2020

Addenda Available:

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address:

Web Address: